No Data
INNOCARE (09969.HK): According to the 2023 Stock-based Incentive plan, 3.83 million restricted stock units were granted.
On December 31, Gelonghui reported that INNOCARE (09969.HK) announced that, on December 31, 2024, the company will grant a total of 3.83 million restricted share units to six grantees according to the 2023 Stock-based Incentive plan, equivalent to approximately 0.22% of the total number of shares issued by the company as of the date of this announcement.
INNOCARE (09969.HK) spent 0.6906 million Hong Kong dollars to buy back 0.114 million shares on December 31.
Gelonghui, December 31丨INNOCARE (09969.HK) announced that on December 31, it spent 0.6906 million HKD to repurchase 0.114 million shares, with a repurchase price per share ranging from 5.94 to 6.12 HKD.
INNOCARE (09969.HK) expects that five to six Innovative Drugs will be approved for market launch in the next three to five years.
The chairman of INNOCARE (09969.HK), Cui Jisong, expressed in his message for 2025 that 2024 will be the first year of the company's 2.0 rapid development phase, with continuous acceleration in commercial growth throughout the year. The sales guidance for the BTK inhibitor, Obinutuzumab, is constantly being revised upwards. Next year will mark the tenth year of the company's development, and it will accelerate research and development, commercialization, and globalization. It is expected that in the next three to five years, five to six Innovative Drugs will be approved for market launch, and three to four products will enter international markets, fulfilling the 2.0 development goals.
December 27 buyback summary | TENCENT, ANTA SPORTS, and others have all conducted buybacks, with TENCENT spending 0.702 billion Hong Kong dollars.
According to a document disclosed by HKEX on December 30, TENCENT (00700.HK) and ANTA SPORTS (02020.HK) repurchased shares. ① TENCENT (00700.HK) repurchased 1.68 million ordinary shares on December 27, involving an amount of 0.702 billion HKD, with a repurchase price ranging from 420.6 HKD to 415.6 HKD per share. Since the repurchase authorization resolution, the cumulative number of repurchased securities is 0.227 billion shares, accounting for 2.413% of the shares issued at the time the ordinary resolution was passed. ② ANTA SPORTS (02020.HK)
INNOCARE (09969.HK) repurchased 0.1 million shares at a cost of 0.599 million Hong Kong dollars on December 27.
Gelonghui, December 27, INNOCARE (09969.HK) announced that on December 27, it spent 0.599 million HKD to repurchase 0.1 million shares.
Express News | Star closing review: The Semiconductors sector mostly declined, while stocks in the Military Industry and Biological Product sectors were relatively active.
